Objective. This study thus aims to test differences between patients with inflammatory bowel disease (IBD) regarding IBD symptomatology, cognitive fusion, and psychological and physical health, as well as to explore whether the maladaptive emotion regulation process of cognitive fusion longitudinally impacts on the baseline and evolution of these outcomes over a period of 18 months.
Additionally, no study has yet examined the causal role of emotion regulation in evolution of physical health in inflammatory bowel disease (IBD).
What does this study add?
Cognitive fusion longitudinally impacted on IBD patients' physical and mental health. These variables were measured over a period of 18 months. Treatment for IBD should include interventions aiming to diminish maladaptive emotion regulation.
Emotion regulation refers to the processes by which individuals influence and shape one's emotions and how one experiences and displays those emotions (Gross, 1998) . It involves the goal to modify the emotion-generative process and the engagement in processes that can alter the emotion trajectory (Gross, Sheppes, & Urry, 2011) . Emotion regulation can thus range from conscious efforts to initiate, inhibit, or modulate one's internal experiences (such as feelings, thoughts, and emotion-related physiological responses) in a given situation to unconscious automatic regulation of those experiences (Gyurak, Gross, & Etkin, 2011) . Emotion regulation can increase or decrease the latency, frequency, intensity, and duration of an emotional response, but not always as desired by the individual (Gross, 1998) , and is so motivated to decrease negative emotions and increase positive ones (Hochschild, 1983; Langston, 1994) . Nevertheless, some types of emotion regulation present paradoxical consequences by increasing aversive emotional states one was trying to regulate (Hayes, Strosahl, & Wilson, 2012) . The type of emotion regulation one uses to deal with internal experiences presents therefore a significant influence on one's well-being. Indeed, previous studies have shown that maladaptive forms of emotion regulation are linked to decreased psychological and physical health (e.g., Gross, 2002; Salovey, Rothman, Detweiler, & Steward, 2000; Segerstrom, Stanton, Alden, & Shortridge, 2003; Song et al., 2015; van Heck & den Oudsten, 2008) . These findings illustrate the relevant association between emotion regulation and health, and by specifically comprising physical health outcomes, argue against the popular, traditionalist stance of the mindbody dualism (Descartes, 1985 (Descartes, [1641 ). One way of regulating internal experiences is becoming fused with them. Cognitive fusion is considered a maladaptive emotion regulation process, key to the Acceptance and Commitment Therapy psychological inflexibility model (Hayes et al., 2012) . This process can be defined as the tendency to get caught up with thoughts' verbal content, that is, to consider thoughts, as trustworthy interpretations of reality, instead of transient and subjective internal experiences (which ability relates to cognitive defusion). Cognitive fusion is related but theoretically different than rumination. While rumination is described as self-focused repetitive thinking on personal negative feelings and self-reflection on the negative events that have triggered these feelings (Nolen-Hoeksema, Wisco, & Lyubomirsky, 2008) , cognitive fusion relates to the excessive attachment with the literal meaning of their internal experiences instead of viewing them as transient processes. As the individual gets entangled with his or her difficult or aversive thoughts, cognitive events tend to overly influence behaviour and the range of possible actions is consequently limited (Hayes et al., 2012) . One's behavioural repertoire is thus retrained by the dominance of internal experiences over other sources of behavioural regulation. This can be exemplified by fusion with thoughts such as 'If I go out, I will feel embarrassed' which may subsequently lead to avoidance patterns of behaviour which aim to control the intensity or frequency of internal experiences, usually uncomfortable ones (e.g., embarrassment, shame, anxiety). Limitations in the range of possible behaviours usually restrain the individual from living a valued, engaged, and full life (Hayes et al., 2012) , leading to diminished life satisfaction and decreased quality of life (e.g., Trompetter et al., 2013) . Cognitive fusion's link with lower levels of mental health is fairly well established. Several studies point out the association between this process and decreased quality of life and mental health (e.g., Ferreira & Trindade, 2015; Gillanders et al., 2014; Trindade & Ferreira, 2014) . Nonetheless, to our current knowledge, only one study has explored the causal, longitudinal role of cognitive fusion in mental health. This study (Trindade, Ferreira, & Pinto-Gouveia, 2017) has namely revealed the impact of cognitive fusion and rumination on depressed mood measured one and a half year later, in a sample of patients with inflammatory bowel disease (IBD). This study seems to establish the impact of cognitive fusion on psychopathology in IBD, a condition often considered as lacking empirical support regarding the effects of associated psychological mechanisms on patients' diminished quality of life and clinical evolution (e.g., McCombie, Mulder, & Gearry, 2013; Sajadinejad, Asgari, Molavi, Kalantari, & Adibi, 2012) .
Inflammatory bowel disease seems to be a much deserving population for studying these aspects due to its adverse symptomatology (abdominal pain, persisting diarrhoea, rectal bleeding, loss of appetite, weight loss, and fatigue), caused by a chronic, auto-immune, and relapsing inflammation of the intestinal system and consequences on quality of life and mental health. The two most common types of IBD are Crohn's disease (CD) and ulcerative colitis (UC), and both illnesses and related symptomatology impair patients' psychosocial functioning and health-related quality of life. It has been demonstrated that IBD may affect all of patients' life domains, from work and household tasks to the quality of intimate relationships (Graff et al., 2006; Irvine, 2008) . Even during periods of remission, patients' wellbeing and psychological functioning tend to be poorer in comparison with the normal population (Blondel-Kucharski et al., 2001; Graff et al., 2009 ). Impaired quality of life in IBD is associated with more relapses and additional medical complications, intensifying the disease process in a cycle of inflammation and psychological suffering (e.g., Levenstein, 2004; Simr en et al., 2002) .
There is thus much pertinence in investigating the link between IBD-related experiences and decreased well-being. It has been considered that the impact of difficult experiences (such as having IBD) on quality of life may depend on the way one deals with these difficulties (Segal, Williams, & Teasdale, 2002) . In this line, it can be hypothesized that different patients, with different patterns of emotion regulation, may present divergences in the way the same illness impacts their well-being. Further, as previous literature has demonstrated the impact of emotion regulation on physical outcomes (e.g., Salovey et al., 2000; Song et al., 2015; van Heck & den Oudsten, 2008) , it can also be hypothesized that cognitive fusion may present a negative impact on patients' physical functioning. Nevertheless, these assumptions lack empirical support. This study thus aims to further expand previous work on the impact of emotion regulation on health outcomes in IBD (Trindade et al., 2017) by testing differences between patients with IBD regarding IBD symptomatology, cognitive fusion, and psychological and physical health, as well as exploring whether cognitive fusion longitudinally impacts on the evolution of these outcomes. We expect that the variables will not present significant changes over time and that both IBD symptomatology and cognitive fusion will influence the baseline and growth levels of psychological and physical health; and that cognitive fusion will be a stronger predictor of these outcomes.
Materials and methods

Setting and participants
Participants were recruited through the Portuguese Association for IBD (APDI), which emailed its members registered as patients (556 members) with an invitation to participate in this investigation. Patients were informed about the voluntary character of the study and the confidentiality of their responses and personal data. Patients who agreed to participate gave their written informed consent and were asked to complete an online survey with self-report measures, in three different waves of assessment equally spaced by 9 months. Data collection thus took place for 18 months, from the end of 2014 to the beginning of 2016. The study was approved by the ethics committees of all involved institutions (FPCE-UC; APDI).
Two hundred and nine (209) participants completed Wave 1, 168 participants (80.38%) completed Wave 2, and 127 participants (60.77%) completed Wave 3. Only, the participants who completed the three waves of assessment (N = 123; 58.85%) were considered be included in the current study. Furthermore, from this pool of 123 participants, seven (5.69%) were excluded for reporting other physical illnesses (breast cancer, fibromyalgia, thalassaemia, multiple sclerosis, diabetes) or psychiatric disorders (bipolar disorder, generalized anxiety disorder).
The sample of this study therefore comprises 116 patients with IBD of both genders: 70 patients (60.34%) diagnosed with Crohn's disease, 43 (37.07%) with ulcerative colitis, and three (2.59%) with IBD-unknown. Table 1 further presents the descriptive statistics of the sample. 
Measures
The online survey included demographic and medical history questions -gender, age, completed level of education, marital status, form of IBD, time since IBD diagnosis, and the occurrence of IBD symptoms during the previous month (10 symptoms measured on a self-report 6-point scale (0: Never; 6: Always): fatigue, abdominal pain, excessive gas, difficulties in gaining or maintaining weight, tenesmus, diarrhoea, nausea, bloody stools, abdominal distension, fever). This scale was specially created for this study to allow the assessment the frequency of the experience of specific IBD symptoms; a total summed score was used, which reflects the level of occurrence of IBD symptomatology during the previous month. Furthermore, participants filled the Portuguese validated versions of the following questionnaires in each wave of assessment:
Cognitive Fusion Questionnaire-7 (Portuguese validation by Costa, Marôco, & Pinto-Gouveia, 2017; CFQ-7; Gillanders et al., 2014) This 7-item instrument was developed to assess one's level of cognitive fusion (e.g., 'It's such a struggle to let go of upsetting thoughts even when I know that letting go would be helpful'). It is rated on a 7-point scale from 1: Never true to 7: Always true. Table 2 .
Statistical analysis
Firstly, preliminary data analyses were conducted to test the adequacy of the data for further analysis. Descriptive and frequency analyses were performed to analyse the sample's demographic and medical features. Furthermore, the relationships between the variables in study were examined through Pearson's correlation coefficients (Cohen, Cohen, West, & Aiken, 2003) . These analyses were conducted using SPSS, version 22.0 (IBM Corp, 2013) .
Latent growth curve models (LGMs; Willett & Sayer, 1994; Windle, 1997) were conducted using structural equation modelling (AMOS, version 22.0; Arbuckle, 2013) to estimate the growth trajectory of IBD symptomatology, cognitive fusion, psychological health, and physical health. This is a longitudinal analysis that estimates growth over a period of time (in the case of the current study, 18 months) that approaches the analysis of repeated measures from the perspective of an individual growth curve for each participant. Each growth curve has a certain baseline level (the intercept factor) and a certain rate of change over time (the slope factor). The intercept factor is a constant for any individual across time and thus describes the initial level of the variable in study (intercept mean) and its individual differences (intercept variance). In turn, the slope factor indicates the average rate of change (slope mean) and individual differences in patterns of growth (slope variance). The direction of the correlation between the intercept and slope factors is also analysed: If positive, it indicates that the lower the initial level, the higher the growth; if negative, it demonstrates that the larger the baseline, the lower the growth. In a second step, hypotheses about predictors of the growth of the outcome measures (psychological health and physical health) were tested. To do so, the models of these variables were conditioned by including IBD symptomatology and cognitive fusion as predictors of the intercept and the slope factors. In this way, one can examine whether these predictors account for individual differences in the initial level of the outcomes and for the differences in the rate of change.
To analyse the adequacy of the models, several goodness of fit was examined: the Comparative Fit Index (CFI), the Tucker and Lewis Index (TLI), and the Incremental Fit Index (IFI) which show that the tested model presents a good adjustment to the empirical data when around .95 (Hu & Bentler, 1999) , and the Standardized Root Mean Squared Residual (SRMR) that demonstrates a good model fit when inferior to .08 (Hu & Bentler, 1999) .
Results
Preliminary analysis
Skewness and Kurtosis' values indicated that the variables in study did not present a significant bias to normal distribution (Skewness varied between À.49 and .58, and Kurtosis between À.63 and .39). The visual inspection of distributions further confirmed the assumption of normality (Kline, 2005) .
Correlation analyses' results are presented in Table 2 , and it is worth observing that cognitive fusion at baseline was negatively linked with psychological health and physical health at baseline and at Wave 2 (9 months later). Also, cognitive fusion at baseline was linked to psychological health at Wave 3 (18 months later).
Non-conditioned models IBD Symptomatology
The LGM was successfully fitted to the levels of IBD symptomatology physical health's at the three waves of assessment: CFI = 1.00; TLI = 1.00; IFI = 1.00; SRMR = .00.
Basal levels of IBD symptomatology were significantly different among participants (b = 61.57; SE = 13.31; Z = 24.66; p < .001) around a mean of 21.21 (SE = 0.88; Z = 24.06; p < .001). Slope's mean indicated a non-significant general change over time (b = À0.51; SE = 0.33; Z = À1.57; p = .117). Furthermore, the growth rate of IBD symptomatology was homogeneous among participants given the non-significant variance around the mean growth (b = À2.15; SE = 5.58; Z = À0.39; p = .700).
Cognitive fusion
The LGM was successfully fitted to cognitive fusion levels assessed at the three waves, as indicated by the excellent model fit: CFI = .98; TLI = .95; IFI = .98; SRMR = .00.
Basal levels of cognitive fusion presented individual differences between participants (b = 80.37; SE = 14.80; Z = 5.43; p < .001) around a mean level of 22.29 (SE = 0.94; Z = 23.74; p < .001). Overall, there was no significant change over time as indicated by the non-significant estimate of slope's mean (b = À0.64; SE = 0.42; Z = À1.51; p = .131). The growth rate of cognitive fusion was homogeneous among participants given the non-significant variance around the mean growth (b = 10.76; SE = 5.71; Z = 1.88; p = .060). The correlation between intercept and slope was À.17 (p = .434).
Psychological health
The LGM was adequately fitted to psychological health's levels at the three waves of assessment: CFI = .97; TLI = .91; IFI = .97; SRMR = .00.
Initial levels of psychological health presented individual differences among participants (b = 215.08; SE = 40.95; Z = 5.25; p < .001) around a mean level of 64.05 (SE = 1.44; Z = 44.29; p < .001). Slope's mean was non-significant (b = 1.19; SE = 0.64; Z = 1.84; p = .065), indicating that there was no significant change over time regarding psychological health's levels. The growth rate was not homogeneous among participants as shown by the significant variance around the mean growth (b = 37.21; SE = 14.47; Z = 2.57; p = .010). The association between intercept and slope was À0.42 (p = .040), indicating that the larger the level of psychological health at baseline, the lower the subsequent rate of change.
Physical health
The LGM was successfully fitted to physical health's levels measured at the three waves: CFI = 1.00; TLI = 1.00; IFI = 1.00; SRMR = .00.
Basal levels of physical health were significantly different among participants (b = 256.75; SE = 47.77; Z = 5.38; p < .001) around a mean level of 63.62 (SE = 1.58; Z = 40.16; p < .001). Slope's mean was found to be significant, indicating a significant tendency to increase at a mean rate of 1.53/yr (SE = 0.69; Z = 2.22; p = .026). Further, the growth rate was not homogeneous among participants as revealed by the significant variance around the mean growth (b = 36.30; SE = 16.55; Z = 2.19; p = .028). The correlation between intercept and slope was À0.46 (p = .037), showing that the higher the level of physical health at baseline, the lower the later rate of change.
Predicting change
Psychological health A conditional model was fitted to data to explore the influence of IBD symptomatology and cognitive fusion on the growth of psychological health (Figure 1) . This model presented a very good fit to the empirical data: CFI = .98; TLI = .94; IFI = .98; SRMR = .01.
Results showed that IBD symptomatology presented a significant impact on psychological health baseline levels (b = À.29, p < .001), indicating that individuals who report more symptomatology present lower levels of psychological health. Nevertheless, it was also shown that IBD symptomatology did not influence the growth rate of psychological health (b = .15, p = .169).
Regarding cognitive fusion, it was shown that this process significantly impacted on psychological health baseline levels with a negative effect of À0.62 (p < .001). Furthermore, the rate of psychological health growth was significantly influenced by cognitive fusion (b = .30, p = .007).
Physical health
Similar results were found for physical health. This conditional model (Figure 2 ) was fitted to data to explore the influence of IBD symptomatology and cognitive fusion on the growth of physical health and showed an excellent fit: CFI = 1.00; TLI = 1.00; IFI = 1.00; SRMR = .01.
The model indicated that IBD symptomatology had a significant negative effect on basal physical health levels (b = À.59, p < .001), demonstrating that individuals who report more IBD symptomatology show lower levels of physical health. However, IBD symptomatology did not present a significant effect on the growth rate of physical health (b = .15, p = .206); that is, IBD symptomatology also did not predict individual differences in the evolution of physical health.
Additionally, results showed that cognitive fusion had a significant negative effect on the baseline levels of physical health (b = À.28; p < .001). Moreover, the rate of physical health growth was significantly impacted by cognitive fusion (b = .26, p = .024).
Discussion
This study examined the progression of IBD symptomatology, cognitive fusion, and psychological and physical health in a sample of patients with IBD, over a time period of 18 months with three assessment moments. Also, we intended to examine the association of IBD symptomatology and cognitive fusion with psychological health and physical health, and explore whether IBD symptomatology and cognitive fusion significantly predict longitudinal changes in these outcomes.
Latent growth curve models results revealed that IBD symptomatology and cognitive fusion's initial levels presented significant differences among participants and that these variables did not present overall significant changes over time. These findings indicate that participants reported different levels of IBD symptomatology and cognitive fusion and also that these variables seem to be fairly stable over time. Results also demonstrated that the change rate of IBD symptomatology and cognitive fusion did not differ significantly among participants.
Regarding psychological health, the LGM analysis showed that its initial levels also differed among participants and that there was no overall change in this variable over the assessed 18 months. Psychological health in patients with IBD thus seems to be generally stable over time. Nevertheless, the change rate of psychological health was demonstrated to differ among participants: Some participants presented similar levels over time, while others' levels increased, and other participants showed decreased psychological health over time. Individuals who presented higher levels at baseline presented a smaller progression over time in psychological health. Similar results were found for physical health with the exception of its overall change over time. Physical health was found to present a tendency to increase over the measured 18 months.
Taking into consideration these data, the clinical features of IBD, and previous considerations regarding the effects of emotion regulation on health (e.g., Gross, 2002; Salovey et al., 2000; Segerstrom et al., 2003; Song et al., 2015; van Heck & den Oudsten, 2008) , two conditional LGMs were tested to investigate the influence of IBD symptomatology and cognitive fusion on the evolution of patients' psychological and physical health over 18 months. Concerning psychological health, it was revealed that both IBD symptomatology and cognitive fusion's levels were negatively associated with psychological health's baseline levels. Furthermore, results indicated that IBD symptomatology did not influence the growth of psychological health, while cognitive fusion did. Findings seem to be particularly relevant by thus indicating that individuals with higher levels of cognitive fusion present lower levels of psychological health that tend to further decrease through the effects of this maladaptive emotion regulation process.
These findings go in line with previous studies demonstrating the effects of coping strategies (e.g., illness perceptions) on self-reported disability (van der Have et al., 2015) and adjustment to the disease (Dorrian, Dempster, & Adair, 2009) in patients with IBD. Our data also are in line with previous research demonstrating the association between cognitive fusion and decreased mental health (e.g., Ferreira & Trindade, 2015; Gillanders et al., 2014; Trindade & Ferreira, 2014) . These results seem to suggest that cognitive fusion, described as the dominance of verbal relations over direct experience in controlling behaviour, is related to overthinking and lack of action (Gillanders et al., 2014; Hayes et al., 2012) , which may ultimately lead to diminished psychological health. Furthermore, as cognitive fusion is linked with other maladaptive processes of the ACT's psychological inflexibility model, such as life values confusion, uncommitted action, and experiential avoidance (Hayes et al., 2012) , it may be possible that these interactions further expand and explain cognitive fusion's detrimental effect on mental functioning. For instance, if fused with thoughts such as 'I can't go out with my friends, because my illness will get in the way' or 'This illness is so embarrassing I can't talk to anyone about it', a patient may tend to avoid activities he actually values and enjoys (e.g., having quality time with friends/family; having close and secure social relationships). Like so, one may rather act uncommittedly with life values and objectives, which can lead to a sense of life unfulfillment and isolation.
The current study also aimed to explore the influence of IBD symptomatology and cognitive fusion on the physical health of patients with IBD. Results indicated that the baseline levels of IBD symptomatology and cognitive fusion were inversely linked with physical health. Also similarly to what was found in the psychological health analysis, it was revealed that IBD symptomatology did not influence the evolution of physical health, while cognitive fusion did present significant effects on this outcome. Thus, IBD patients with higher levels of cognitive fusion present lower levels of physical health that tend to further decline with the influence of this emotion regulation process.
These findings can be explained under the framework of several models regarding the link between emotion regulation and physical health. According to the transactional/ interactional stress-illness model (van Heck & den Oudsten, 2008) , emotion regulation, by determining the selection, manipulation, and evaluation of difficult events, modulates physiological responses to stressors. In this line, results from the current study indicate that cognitive fusion may amplify the perceived importance and meaning of unwanted/ difficult internal experiences, augmenting the frequency and intensity of related negative emotions, and thus impacting on physiological levels. When facing disease-related stressful situations, patients with IBD may get fused with difficult thoughts about their condition, symptoms, or clinical evolution, which expectedly leads to negative affect and to the further occurrence of negative internal experiences (Hayes et al., 2012) . One may hypothesize that the link between cognitive fusion and subsequent depressed mood, found in patients with IBD (Trindade et al., 2017) , may similarly explain the impact of cognitive fusion on physical health. Given that depressed mood can stimulate the production of proinflammatory cytokines, modulating the clinical expression of IBD (Kiecolt-Glaser, McGuire, Robles, & Glaser, 2002; Tach e & Bernstein, 2009 ), high depressive levels may thus lead to diminished physical health in patients with IBD. Along these lines, cognitive fusion's depressenogenic effects may explain its impact on physical health.
Furthermore, the health behaviour model proposes that emotion regulation influences health-related behaviours and coping behaviours (e.g., eating healthy, taking the prescribed medications), which mediate the link between emotion regulation and physical health (van Heck & den Oudsten, 2008) . Accordingly, it can be suggested that patients with IBD, when fused with thoughts regarding their perception of the illness and their current health may engage in health-degrading habits. For example, if a patient gets entangled with thoughts such as 'I'm always going to be this sick', 'diet won't impact my health', or 'medication only makes me feel worse', he or she may tend to neglect medical recommendations, and present poor adherence to medication/diet and attendance to medical appointments.
These findings present nonetheless some limitations. The sample size and dropout impose some caution in the interpretation of the findings. Larger samples are preferable to conduct SEM models (e.g., Wolf, Harrington, Clark, & Miller, 2013) ; nevertheless, it is generally recommended that LGM analyses should be conducted using samples of at least 100 (Hamilton, Gagne, & Hancock, 2003) , which is the case of the current study. Further, the sample comprises Portuguese patients who were recruited through an association via an email invitation. Future research should confirm this study's findings using samples of other cultures and recruited by different methods (e.g., in hospital settings). The self-report nature of this study may also represent a methodological limitation; future studies ought to comprise laboratorial medical indices and clinical interviews to assess psychological and physical health. The longitudinal analysis of the effects of other emotion regulation processes such as acceptance and mindfulness on health could also be of interest. Nevertheless, this study provides important novel data regarding the longitudinal impact of emotion regulation, namely cognitive fusion, on psychological and also physical health outcomes in IBD.
The present study indeed may suggest that promoting adaptive emotion regulation strategies may improve IBD patients' psychological and physical health. Future studies should nonetheless attempt to repeat this study's findings with larger samples to support the development of psychotherapeutic interventions for patients with IBD. If this study's results are corroborated, ACT-based interventions would probably be helpful to provide effective results due to their focus on the promotion of defusion and acceptance abilities and committed action. These interventions could represent decreases in the cost of IBD treatment and in the use of drugs with adverse side effects, in addition to improving patients' mental health and quality of life.
